021-51111890
购物车（）
sales@molnova.cn
Fibrinogen-Binding Peptide
CAS No. 137235-80-4
Fibrinogen-Binding Peptide ( —— )
产品货号. M30434 CAS No. 137235-80-4
Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen, a soluble plasma protein, is a cofactor in platelet activation. It is converted to fibrin in a reaction catalyzed by thrombin.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Fibrinogen-Binding Peptide
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen, a soluble plasma protein, is a cofactor in platelet activation. It is converted to fibrin in a reaction catalyzed by thrombin.
-
产品描述Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen, a soluble plasma protein, is a cofactor in platelet activation. It is converted to fibrin in a reaction catalyzed by thrombin.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number137235-80-4
-
分子量565.62
-
分子式C25H39N7O8
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 83.33 mg/mL (147.33 mM)
-
SMILES——
-
化学全称Sequence:{Glu}{His}{Ile}{Pro}{Ala}
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Gartner TK, et al. The peptide Glu-His-Ile-Pro-Ala binds fibrinogen and inhibits platelet aggregation and adhesion to fibrinogen and vitronectin. Proc Soc Exp Biol Med. 1991 Oct;198(1):649-55.
产品手册
关联产品
-
Anisatin
Anisatin, a toxic, insecticidally active component of Sikimi plant, is a potent GABA antagonist.
-
3,4-Dimethoxychalcon...
3,4-Dimethoxychalcone 是一种潜在的抗菌和抗氧化剂。
-
Tagitinin C
Tagitinin C 是一种可从肿柄菊中分离得到的倍半萜类化合物。Tagitinin C 具有抗癌活性，能抑制人胶质母细胞瘤 U373 细胞增殖，IC50 为 6.1 μg/mL。Tagitinin C 可诱导 U373 细胞死亡，用于胶质母细胞瘤研究。
